Association between clinical characteristics within 6 h of ICU admission and 30-day mortality risk in immunocompromised sepsis patients: development and validation of a machine learning model based on the MIMIC-IV database - Summary - MDSpire
Advertisement
Association between clinical characteristics within 6 h of ICU admission and 30-day mortality risk in immunocompromised sepsis patients: development and validation of a machine learning model based on the MIMIC-IV database
To develop and validate a machine learning model for predicting 30-day mortality in immunocompromised sepsis patients using clinical data within 6 h of ICU admission.
Approach:
Study Design: Retrospective cohort study utilizing data from MIMIC-IV and eICU databases.
Patient Selection: Included adult immunosuppressed patients meeting Sepsis-3 criteria.
Data Collection: Clinical indicators within 6 h of ICU admission were extracted.
Model Development: Constructed predictive models using seven machine learning algorithms.
Model Assessment: Evaluated discriminative capabilities using AUC, calibration curves, and DCA.
External Validation: Best-performing model validated using eICU dataset and SHAP analysis.
Key Findings:
Included 2,494 immunosuppressed sepsis patients with a 30-day mortality rate of 33.4%.
Final prediction model included 10 feature variables: Weight, APS-III score, Urine output, Prothrombin Time, Blood Urea Nitrogen, SOFA score, Red Blood Cell count, Platelet count, Age, and Mean Corpuscular Hemoglobin Concentration.
Support Vector Machine (SVM) model showed best predictive performance with an AUC of 0.794 in the validation set.
External validation on the eICU dataset yielded an AUC of 0.847.
Interpretation:
The SVM-based prediction model effectively predicts 30-day mortality risk in immunosuppressed sepsis patients using easily obtainable clinical indicators.
Limitations:
Retrospective design may introduce bias.
Data derived from specific databases may limit generalizability.
Conclusion:
The study developed a practical tool for early identification of high-risk immunosuppressed sepsis patients.